Shared Competence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shared competence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shared Competence Today - Breaking & Trending Today

Investegate |CompuGroup Medical SE & Co Announcements | CompuGroup Medical SE & Co: Universitätsklinik Hamburg-Eppendorf (UKE) decides for a future with CGM CLINICAL


DGAP-News: CompuGroup Medical SE & Co. KGaA
/ Key word(s): Miscellaneous
Universitätsklinik Hamburg-Eppendorf (UKE) decides for a future with CGM CLINICAL
15.04.2021 / 09:05
The issuer is solely responsible for the content of this announcement.
Koblenz. CompuGroup Medical (CGM), one of the world s leading providers of e-health solutions, announced today that the medical center Universitätsklinik Hamburg-Eppendorf (UKE), one of Europe s leading university clinics, selected the CGM CLINICAL hospital information system as the core enterprise-wide electronic health record (EHR) system. For more than a decade, UKE has been a pioneer in digitization of healthcare and is now taking the next step by choosing an innovative partner. Using cutting-edge features will further propel UKE s experience in case as part of an integrated patient journey. ....

Rheinland Pfalz , Nordrhein Westfalen , Claudia Thom , Michael Franz , Christian Gerloff , Marco Siebener , Hannes Reichl , Center Hamburg , Cancer Center , University Heart Vascular Center , Compugroup Medical Se Co , Compugroup Medical , Professor Christian Gerloff , Vice Medical Director , Managing Director Inpatient , Social Care , University Heart , Vascular Center , Medical Center Hamburg Eppendorf , Hanseatic City , Shared Competence , Group Medical , ரைன்லேண்ட் ப்ஃப்யால்ஸ் , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , கிளாடியா தோம் , மைக்கேல் ஃப்ரான்ஸ் ,

Evotec AG: Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy for Heart Failure


Evotec AG: Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy for Heart Failure
RISK-REWARD-SHARING PARTNERSHIP LEVERAGES COMPLEMENTARY PLATFORMS
HAMBURG, GERMANY / ACCESSWIRE / February 4, 2021 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that the Company has entered into a multi-year partnership with the Medical Center Hamburg-Eppendorf ( UKE ) for the development of a highly innovative first-in-class cell therapy approach for the treatment of heart failure.
Under the terms of the partnership, Evotec and UKE will leverage their complementary strengths for the development of a new cell therapy approach using Engineered Heart Tissue for the treatment of heart failure. Heart failure is frequently associated with ischemic heart disease and often comes with a poor prognosis. Mortality is comparable to that of the most common cancers, with ....

Nordrhein Westfalen , Volker Braun , Thomas Eschenhagen , Gabriele Hansen , Center Hamburg , University Medical Center , Institute Of Experimental Pharmacology , Boehringer Ingelheim , Evotec Se Frankfurt Stock Exchange , Head Of Global Corporate Communications Marketing , Bristol Myers Squibb , Novo Nordisk , Frankfurt Stock Exchange , Medical Center Hamburg Eppendorf , Engineered Heart Tissue , Cord Dohrmann , Chief Scientific Officer , Experimental Pharmacology , University Medical , Shared Competence , Global Corporate Communications , Global Investor Relations , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , வோல்கர் மூளை , கேப்ரியல் ஹேன்சன் , மையம் ஹாம்பர்க் ,